Raymond James & Associates Mirum Pharmaceuticals, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 137,628 shares of MIRM stock, worth $5.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

137,628

Previous 144,214 4.57%

Holding current value

$5.66 Million

Previous $4.93 Million 8.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$33.68 - $44.74 $221,816 - $294,657	-6,586 Reduced 4.57%	137,628 $5.37 Million
Q2 2024 Jul 19, 2024	BUY	$23.57 - $34.85 $321,754 - $475,737	13,651 Added 10.46%	144,214 $4.93 Million
Q1 2024 Apr 22, 2024	SELL	$24.92 - $30.02 $127,565 - $153,672	-5,119 Reduced 3.77%	130,563 $3.28 Million
Q4 2023 Jan 16, 2024	BUY	$27.14 - $34.93 $799,951 - $1.03 Million	29,475 Added 27.75%	135,682 $4.01 Million
Q3 2023 Oct 24, 2023	BUY	$24.63 - $32.85 $951,185 - $1.27 Million	38,619 Added 57.14%	106,207 $3.36 Million
Q2 2023 Jul 25, 2023	BUY	$23.51 - $30.09 $916,913 - $1.17 Million	39,001 Added 136.43%	67,588 $1.75 Million
Q1 2023 Apr 14, 2023	BUY	$19.19 - $24.1 $169,524 - $212,899	8,834 Added 44.72%	28,587 $686,000
Q4 2022 Feb 08, 2023	SELL	$17.59 - $23.83 $901,593 - $1.22 Million	-51,256 Reduced 72.18%	19,753 $385,000
Q3 2022 Oct 25, 2022	BUY	$19.98 - $29.44 $508,271 - $748,924	25,439 Added 55.82%	71,009 $1.49 Million
Q2 2022 Aug 12, 2022	BUY	$18.42 - $27.5 $616,554 - $920,480	33,472 Added 276.67%	45,570 $887,000
Q1 2022 May 11, 2022	SELL	$15.5 - $23.93 $101,602 - $156,861	-6,555 Reduced 35.14%	12,098 $266,000
Q4 2021 Feb 08, 2022	SELL	$13.05 - $19.35 $15,816 - $23,452	-1,212 Reduced 6.1%	18,653 $298,000
Q3 2021 Nov 02, 2021	BUY	$13.95 - $20.18 $83,574 - $120,898	5,991 Added 43.18%	19,865 $396,000
Q2 2021 Aug 11, 2021	SELL	$15.84 - $20.6 $316,800 - $412,000	-20,000 Reduced 59.04%	13,874 $240,000
Q1 2021 May 14, 2021	BUY	$16.29 - $21.92 $8,812 - $11,858	541 Added 1.62%	33,874 $671,000
Q4 2020 Feb 12, 2021	BUY	$15.75 - $25.45 $524,994 - $848,324	33,333 New	33,333 $582,000
Q1 2020 Apr 21, 2020	SELL	$9.38 - $23.79 $82,947 - $210,374	-8,843 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$6.84 - $25.9 $60,486 - $229,033	8,843 New	8,843 $217,000

Others Institutions Holding MIRM

# of Institutions

173

Shares Held

54.2M

Call Options Held

96.1K

Put Options Held

54.8K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.51B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Mirum Pharmaceuticals, Inc. Transaction History